Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | HBB | P68871 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CA5A | P35218 | 1/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL719520 | 1.00 | ALDH1A1 (0.72) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL9323936 | 1.00 | ALDH1A1 (0.72) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL16341718 | 1.00 | ALDH1A1 (0.72) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL16341166 | 1.00 | ALDH1A1 (0.72) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL1311257 | 1.00 | ALDH1A1 (0.72) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL719096 | 0.96 | ALDH1A1 (0.67) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL1011508 | 0.88 | — | — | |
| SCHEMBL27630239 | 0.87 | ALDH1A1 (0.59) | ALDH1A1TDP1MEN1KMT2ALMNA | |
| SCHEMBL6426269 | 0.87 | — | — | |
| SCHEMBL25275677 | 0.85 | ALDH1A1 (0.56) | ALDH1A1TDP1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2407449-B1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2015-01-07 | — | — | EP | claimed |
| US-8765993-B2 | One-pot production of carbamates using solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-07-01 | — | — | US | claimed |
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | UNIVERSIDAD POLITECNICA DE VALENCIA (ES) | 2012-03-01 | — | — | US | claimed |
| EP-2407449-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2012-01-18 | — | — | EP | claimed |
| EP-2407449-B1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2015-01-07 | — | — | EP | disclosed |
| US-8765993-B2 | One-pot production of carbamates using solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-07-01 | — | — | US | disclosed |
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | UNIVERSIDAD POLITECNICA DE VALENCIA (ES) | 2012-03-01 | — | — | US | disclosed |
| EP-2407449-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2012-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053359-A1 | ONE-POT PRODUCTION OF CARBAMATES USING SOLID CATALYSTS | CA7, CA2, CA4 | ALDH1A1 1941/4885TDP1 1893/4885MEN1 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.